πŸ‡ΊπŸ‡Έ FDA
Patent

US 11642379

Hematopoietic stem cell engraftment

granted A61KA61K2039/505A61K2039/545

Quick answer

US patent 11642379 (Hematopoietic stem cell engraftment) held by The Regents of the University of California expires Mon May 04 2043 00:00:00 GMT+0000 (Coordinated Universal Time). Status: granted.

Key facts

Applicant
The Regents of the University of California
Grant date
Tue May 09 2023 00:00:00 GMT+0000 (Coordinated Universal Time)
Expiration
Mon May 04 2043 00:00:00 GMT+0000 (Coordinated Universal Time)
Claims
17
CPC classes
A61K, A61K2039/505, A61K2039/545, A61K35/28, A61K39/3955